★ Sign in to follow
LM

L Miels

GB·RNS (LSE)
GlaxoSmithKline plc
Total declarations
62
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (1 ops.)
€91k

Latest filing published 02 Mar 2021 for GlaxoSmithKline plc.

Filing timeline

BuySale
L Miels

Insider track record

Disclosed buys
0
Disclosed sells
1
Signal history

L Miels: trading record in brief

This profile gathers the share dealings of L Miels in GlaxoSmithKline plc. The record holds 62 filings, for trades running from 11 December 2017 to 1 March 2021.

The open-market record consists of 1 sale worth €91k, with no purchase. Other entries cover 61 share grants. So far in 2021, the count stands at no purchases and 1 sale.

The newest entry dates from 2 March 2021: a share grant, in GlaxoSmithKline plc. Between a trade and the moment it shows up on RNS (LSE), the median delay is 2 days. The regulation allows three business days to notify a trade (UK MAR). Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.

Companies and markets linked to L Miels

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations62 total
  • ◆
    L Miels
    President, Global PharmaceuticalsExecutivesGlaxoSmithKline plc
    0FCA-NSM
    13,820 sharesN/AISIN GB0009252882FCA-NSM:3897443-8
  • ▼
    L Miels
    President, Global PharmaceuticalsExecutivesGlaxoSmithKline plc
    78,657 GBP0FCA-NSM
    6,501 shares@ £12.0992N/AISIN GB0009252882FCA-NSM:3897443-9
  • ◆
    L Miels
    President, Global PharmaceuticalsExecutivesGlaxoSmithKline plc
    0FCA-NSM
    29,048 sharesLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3882407-8
  • ◆
    L Miels
    President, Global PharmaceuticalsExecutivesGlaxoSmithKline plc
    0FCA-NSM
    175,482 sharesN/AISIN GB0009252882FCA-NSM:3879317-9
  • ◆
    L Miels
    President, Global PharmaceuticalsExecutivesGlaxoSmithKline plc
    1M GBP0FCA-NSM
    78,431.373 shares@ £12.75n/aISIN GB0009252882FCA-NSM:3878377-1
  • ◆
    L Miels
    President, Global PharmaceuticalsExecutivesGlaxoSmithKline plc
    0FCA-NSM
    12,409 sharesN/AISIN GB0009252882FCA-NSM:3878373-9
  • ◆
    L Miels
    President, Global PharmaceuticalsExecutivesGlaxoSmithKline plc
    0FCA-NSM
    244,372 sharesN/AISIN GB0009252882FCA-NSM:3878367-10
  • ◆
    L Miels
    President, Global PharmaceuticalsExecutivesGlaxoSmithKline plc
    9,266 GBP0FCA-NSM
    665 shares@ £13.934London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3851939-10
  • ◆
    L Miels
    President, Global PharmaceuticalsExecutivesGlaxoSmithKline plc
    40,571 GBP0FCA-NSM
    2,887.894 shares@ £14.0488London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3850615-7
  • ◆
    L Miels
    President, Global PharmaceuticalsExecutivesGlaxoSmithKline plc
    55 GBP0FCA-NSM
    4 shares@ £13.8725London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3847444-7
  • ◆
    L Miels
    President, Global PharmaceuticalsExecutivesGlaxoSmithKline plc
    9,151 GBP0FCA-NSM
    642 shares@ £14.254London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3748390-10
  • ◆
    L Miels
    President, Global PharmaceuticalsExecutivesGlaxoSmithKline plc
    40,043 GBP0FCA-NSM
    2,780.62 shares@ £14.4008ISIN GB0009252882FCA-NSM:3746934-9
  • ◆
    L Miels
    President, Global PharmaceuticalsExecutivesGlaxoSmithKline plc
    71 GBP0FCA-NSM
    5 shares@ £14.258London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3746881-6
  • ◆
    L Miels
    President, Global PharmaceuticalsExecutivesGlaxoSmithKline plc
    373,152 GBP0FCA-NSM
    25,999.998 shares@ £14.352N/AISIN GB0009252882FCA-NSM:3711543
  • ◆
    L Miels
    President, Global PharmaceuticalsExecutivesGlaxoSmithKline plc
    9,047 GBP24FCA-NSM
    568 shares@ £15.92818.5% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3657059-10
  • ◆
    L Miels
    President, Global PharmaceuticalsExecutivesGlaxoSmithKline plc
    39,566 GBP30FCA-NSM
    2,508.442 shares@ £15.773381.4% of flowISIN GB0009252882FCA-NSM:3656063-9
  • ◆
    L Miels
    President, Global PharmaceuticalsExecutivesGlaxoSmithKline plc
    48 GBP22FCA-NSM
    3 shares@ £16.100.1% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3653502-7
  • ◆
    L Miels
    President, Global PharmaceuticalsExecutivesGlaxoSmithKline plc
    47,204 GBP0FCA-NSM
    3,010.736 shares@ £15.6785ISIN GB0009252882FCA-NSM:3564652-7
  • ◆
    L Miels
    President, Global PharmaceuticalsExecutivesGlaxoSmithKline plc
    10,794 GBP0FCA-NSM
    699 shares@ £15.442London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3564578-10
  • ◆
    L Miels
    President, Global PharmaceuticalsExecutivesGlaxoSmithKline plc
    61 GBP22FCA-NSM
    4 shares@ £15.3550.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3561524-6
  • ◆
    L Miels
    President Global PharmaceuticalsExecutivesGlaxoSmithKline plc
    1M GBP30FCA-NSM
    65,213 shares@ £16.59796.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20200220153005_3500898_20200331164942585_19927-7
  • ◆
    L Miels
    President, Global PharmaceuticalsExecutivesGlaxoSmithKline plc
    0FCA-NSM
    270,447 sharesN/AISIN GB0009252882FCA-NSM:LSE20200219163501_3499502_20200331164942435_18546-7
  • ◆
    L Miels
    President, Global PharmaceuticalsExecutivesGlaxoSmithKline plc
    0FCA-NSM
    181,957 sharesN/AISIN GB0009252882FCA-NSM:LSE20200219162845_3499497_20200331164942435_18543-10
  • ◆
    L Miels
    President, Global PharmaceuticalsExecutivesGlaxoSmithKline plc
    0FCA-NSM
    15,796 sharesN/AISIN GB0009252882FCA-NSM:LSE20200219161740_3499482_20200331164942434_18534-9
  • ◆
    L Miels
    President, Global PharmaceuticalsExecutivesGlaxoSmithKline plc
    5,854 GBP22FCA-NSM
    327 shares@ £17.9020.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20200115070004_14384225_20200331164952131_13473-3

25 of 62 declarations

Related entities

No related entities found.